Passer au contenu principal

Costeff syndrome

Costeff syndrome is an inherited condition characterised by vision loss, delayed development, and movement problems. Vision loss is primarily caused by degeneration (atrophy) of the optic nerves, which carry information from the eyes to the brain. This optic nerve atrophy often begins in infancy or early childhood and results in vision impairment that worsens over time. Some affected individuals have rapid and involuntary eye movements (nystagmus) or eyes that do not look in the same direction (strabismus).

Description

Costeff syndrome is an inherited condition characterised by vision loss, delayed development, and movement problems. Vision loss is primarily caused by degeneration (atrophy) of the optic nerves, which carry information from the eyes to the brain. This optic nerve atrophy often begins in infancy or early childhood and results in vision impairment that worsens over time. Some affected individuals have rapid and involuntary eye movements (nystagmus) or eyes that do not look in the same direction (strabismus).

Development of motor skills, such as walking, is often delayed in people with Costeff syndrome. Affected individuals may also have speech difficulties (dysarthria). While some people with Costeff syndrome have mild to moderate intellectual disability, many have normal intelligence.

Movement problems in people with Costeff syndrome develop in late childhood and include muscle stiffness (spasticity), impaired muscle coordination (ataxia), and involuntary jerking movements (choreiform movements). As a result of these movement difficulties, individuals with Costeff syndrome may require wheelchair assistance.

Costeff syndrome is associated with increased levels of a substance called 3-methylglutaconic acid in the urine (3-methylglutaconic aciduria). The amount of this substance does not appear to influence the signs and symptoms of the condition. Costeff syndrome is one of a group of metabolic disorders that can be diagnosed by the presence of 3-methylglutaconic aciduria. People with Costeff syndrome also have high levels of another acid called 3-methylglutaric acid in their urine.

Inheritance patterns

The source lists the following possible inheritance patterns: Autosomal recessive. More than one pattern can apply in different cases.

Other names

3-methylglutaconic aciduria type 3

3-methylglutaconic aciduria type III

Autosomal recessive OPA3

Autosomal recessive optic atrophy 3

Costeff optic atrophy syndrome

Infantile optic atrophy with chorea and spastic paraplegia

Iraqi Jewish optic atrophy plus

MGA, type III

MGA3

OPA3 defect

Optic atrophy plus syndrome

Related patient information and medicines

Syndrome de fatigue chronique

Patient information leaflet

Syndrome de fatigue chronique

Chronic fatigue syndrome (CFS), sometimes known as myalgic encephalomyelitis (ME) or myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) , is a condition where there is long-term disabling tiredness (fatigue). Most people with also have one or more ... Chronic fatigue syndrome (CFS) is defined as persistent or recurrent debilitating.

Syndrome de vibration main-bras

Patient information leaflet

Syndrome de vibration main-bras

Syndrome de vibration main-bras (sometimes abbreviated to HAVS) causes changes in the sensation of the fingers which can lead to permanent numbness of fingers, muscle weakness and, in some cases, bouts of white finger. It is caused by working with vibrating tools. In woman, sometimes the oral contraceptive pill The combined oral contraceptive (COC).

Côte cervicale

Patient information leaflet

Côte cervicale

About 1 in 100 people are born with an extra rib called a cervical rib. About 1 in 10 people who have a cervical rib develop thoracic outlet syndrome. This happens if the cervical rib squashes the nerves and blood vessels going into the arm. Treatment can include painkillers, physiotherapy and sometimes surgery to relieve the compression caused.

Mort subite du nourrisson

Patient information leaflet

Mort subite du nourrisson

However, you can reduce the risk of cot death by the measures detailed below. The most important are to lay your baby on his or her back to sleep (not on their front or side) and to create a smoke-free zone for your baby. What is cot death. Mort subite du nourrisson is more properly known as sudden infant death syndrome (SIDS). It is the term used to describe the.

Syndrome de Wolff-Parkinson-White

Patient information leaflet

Syndrome de Wolff-Parkinson-White

Syndrome de Wolff-Parkinson-White is not common but can cause a fast heart rate or other heart rhythm abnormalities from time to time. Treatment can be given for the fast heart rate and also to prevent any further episodes. What is Wolff-Parkinson-White syndrome. In Wolff-Parkinson-White (WPW) syndrome there is an extra connection (an accessory.

Syndrome de réalimentation

Patient information leaflet

Syndrome de réalimentation

Syndrome de réalimentation was first described in Far East prisoners after the second world war when they developed insuffisance cardiaque after starting to eat again after a prolonged period of starvation. What is refeeding syndrome. Syndrome de réalimentation est a dangerous and life threatening shift of fluids and body salts (electrolytes) that can occur when.

Lectures complémentaires et références

Historique de l'article

Les informations sur cette page sont rédigées et examinées par des cliniciens qualifiés.
  • 18 Aug 2020 | Dernière version
  • 1 Feb 2019 | Publié à l'origine

Participez à la conversation

Partagez vos pensées ou expériences avec les autres dans notre communautés de patients.

Avertissement : The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Pharmacie en ligne, traitements et services de santé

Accès simple à des traitements fiables et à des services de santé en ligne.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Inscrivez-vous à la newsletter Patient

Votre dose hebdomadaire de conseils de santé clairs et fiables - rédigés pour vous aider à vous sentir informé, confiant et maître de la situation.

Veuillez entrer une adresse e-mail valide

En vous abonnant, vous acceptez notre Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.